Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1991-05-30
1992-05-12
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514448, 514461, 514543, 514568, 514570, 549 71, 549499, 549501, 560 51, 560 53, 562549, 562463, 562464, A61K 31235, A61K 3138, C07C 6978, C07D33332
Patent
active
051128640
ABSTRACT:
This invention relates to novel compounds for treating inflammatory conditions by inhibition of phospholipase A.sub.2 activity of the formula ##STR1## wherein X is oxygen, sulfur or --CH.dbd.CH--; wherein R.sup.1 is hydrogen, alkyl of 1 to 6 carbons or a pharmaceutically acceptable cation;
REFERENCES:
patent: 3255241 (1966-06-01), Schultz et al.
patent: 3912656 (1975-10-01), Andrews et al.
patent: 3919250 (1975-11-01), Pauling et al.
patent: 4015010 (1977-03-01), Houlihan et al.
patent: 4469885 (1984-09-01), Djuric et al.
Djuric Stevan W.
Docter Stephen H.
Haack Richard A.
G. D. Searle & Co.
Hollrah Glennon H.
Kovacevic Cynthia S.
Matukaitis Paul D.
Russell Mark W.
LandOfFree
PLA.sub.2 inhibitors as antiinflammatories does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PLA.sub.2 inhibitors as antiinflammatories, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PLA.sub.2 inhibitors as antiinflammatories will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2426238